Cartesian Growth Corp II (NASDAQ:RENE) price on current trading day, rose 0.28% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.55.
A look at the stock’s price movement, the level at last check in today’s session was $11.52, moving within a range at $11.54 and $11.56. The beta value (5-Year monthly) was -0.018 while the PE ratio in trailing twelve months stood at 31.30. Turning to its 52-week performance, $11.58 and $10.85 were the 52-week high and 52-week low respectively. Overall, RENE moved 1.02% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cartesian Growth Corp II’s market cap currently stands at around $249.75 million, with investors looking forward to this quarter’s earnings report slated for in November.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RENE is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
RENE’s current price about 0.57% and 1.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 90.87, while 7-day volatility ratio is 0.09% and 0.07% in the 30-day chart. Further, Cartesian Growth Corp II (RENE) has a beta value of -0.02, and an average true range (ATR) of 0.01.
If we refocus on Cartesian Growth Corp II (NASDAQ:RENE), historical trading data shows that trading volumes averaged 36380.0 over the past 10 days and 97.38K over the past 3 months. The company’s latest data on shares outstanding shows there are 21.62 million shares.
The 26.59% of Cartesian Growth Corp II’s shares are in the hands of company insiders while institutional holders own 72.94% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 73.0 on 2024-09-30. Current price change has pushed the stock 5.59% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RENE stock continues to rise going into the next quarter.
